Latest market price
137.19
+1.29+0.95%
EHCQT77Encompass Health Corporation·NYSE
137.19+0.95%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index—P/E21.44EPS (ttm)6.40Insider Own1.70%Shs Outstand98.65MPerf Week10.55%
Market Cap13.53BForward P/E19.95EPS next Y6.88Insider Trans-14.28%Shs Float97.65MPerf Month14.52%
Enterprise Value16.23BPEG1.78EPS next Q1.59Short Float3.39%Perf Quarter24.15%
Income645.00MP/S2.14EPS this Y17.85%Short Ratio3.69Perf Half Y28.65%
Sales6.34BP/B3.80EPS next Y9.89%ROA8.52%Short Interest3.31MPerf YTD29.25%
Book/sh36.10P/C178.08EPS next 5Y12.07%ROE25.17%52W High138.35 -0.84%Perf Year17.45%
Cash/sh0.77P/FCF29.55EPS past 3/5Y27.07% 14.22%ROIC13.75%52W Low92.77 47.88%Perf 3Y124.06%
Dividend Est.0.84 (0.61%)EV/EBITDA10.45Sales past 3/5Y10.92% 10.73%Gross Margin38.53%Volatility3.34% 2.79%Perf 5Y152.33%
Dividend TTM0.78 (0.57%)EV/Sales2.56EPS Y/Y TTM20.98%Oper. Margin18.32%ATR (14)3.95Perf 10Y331.42%
Dividend Ex-DateJan 04, 2027Quick Ratio1.09Sales Y/Y TTM9.37%Profit Margin10.17%RSI (14)70.51Recom2.19
Dividend Gr. 3/5Y-4.46% -4.71%Current Ratio1.09EPS Q/Q23.58%SMA209.30%Beta0.82Target Price154.86
Payout11.93%Debt/Eq0.78Sales Q/Q8.93%SMA5011.37%Rel Volume1.56Prev Close135.90
Employees30,226LT Debt/Eq0.77EarningsFeb 04SMA20024.47%Avg Volume1.01MPrice137.19
IPO DateSep 24, 1986Option/ShortYes / YesEPS/Sales Surpr.11.68% 0.49%Net Debt/EBITDA1.74Volume1,583,182Change0.95%
Analyst Ratings
DateActionAnalystRatingTarget
Nov-02-26ReiteratedMizuho SecuritiesBuy$95 → $155
Oct-30-26ReiteratedRaymond JamesStrong Buy$150 → $155
Oct-30-26ReiteratedUBSBuy$155 → $165
Oct-30-26ReiteratedKeybancOverweight$150
Oct-30-26ReiteratedTruist SecuritiesBuy$150 → $156
Oct-29-26ReiteratedBarclaysOverweight$144 → $151
Sep-28-26ReiteratedRaymond JamesStrong Buy$85 → $150
Aug-07-26ReiteratedTruist SecuritiesBuy$140 → $150
Aug-07-26ReiteratedUBSBuy$150 → $155
Aug-06-26ReiteratedBarclaysOverweight$140 → $144
Latest News· Times ET
Nov-02-26
Oct-30-26
Oct-29-26
Oct-28-26
Oct-26-26
Oct-23-26
Oct-22-26
Oct-21-26
Company

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue6,3395,9355,3734,801—————
Cost of Goods Sold Incl. D&A3,8963,3703,1402,818—————
Gross Profit2,4422,5652,2331,983—————
Selling, General and Administrative Excl. Other293295267258—————
Research and Development
0000—————
Other Operating Expense9891,2171,102993—————
Operating Income1,1611,053865732—————
Interest Expense127123137144—————
Unusual Expense
—————————
Non-Operating Income (Expense)32232319—————
Net Income Before Taxes1,067953750607—————
Income Taxes218193150132—————
Consolidated Net Income645566456352—————
Net Income From Continuing Operations846760599475—————
Net Income645566456352—————
EPS (Recurring)6.485.624.533.54—————
EPS (Basic, Before Extraordinaries)6.485.624.533.54—————
EPS (Diluted)6.405.544.463.47—————
EBITDA1,5531,4041,1871,025—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio21.4419.1620.7119.23—————
Price To Sales Ratio2.121.811.721.39—————
Gross Margin38.5243.2241.5641.30—————
Operating Margin18.3217.7416.1015.25—————
Net Margin10.189.548.497.33—————
Shares Outstanding98101100100—————
Market Capitalization13,44510,7209,2356,672—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$143.69$129.60$115.51$101.42$87.33● Close Price0.00M6.61M13.22M19.82M26.43MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Price Andrew LChief Accounting OfficerAug 31 '26Sale120.935,211630,16669,483Sep 01
Darby John PatrickEVP, Gen Counsel & SecretaryAug 31 '26Option Exercise35.064,858170,32179,899Sep 01
Darby John PatrickEVP, Gen Counsel & SecretaryAug 31 '26Sale121.094,858588,25575,041Sep 01
COLTHARP DOUGLAS EEVP & Chief Financial OfficerAug 10 '26Sale125.3818,8692,365,79550,508Aug 11
Tarr Mark JPresident & CEOAug 10 '26Sale125.47173,14821,724,096267,814Aug 11
Darby John PatrickEVP, Gen Counsel & SecretaryAug 10 '26Sale125.958,9061,121,71175,041Aug 11
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Option Exercise32.9427,694912,24097,071May 18
COLTHARP DOUGLAS EEVP & Chief Financial OfficerMay 15 '26Sale106.8327,6942,958,55069,377May 18
Tuer Patrick WilliamEVP, Chief Operating OfficerMay 11 '26Sale104.5668271,31024,755May 12
Fay EdmundSr. Vice Pres. and TreasurerMar 09 '26Sale107.0011,9371,277,25989,325Mar 10
Tarr Mark JPresident & CEOFeb 11 '26Sale111.64150,00016,746,689377,070Feb 12
Tuer Patrick WilliamEVP, Chief Operating OfficerFeb 10 '26Sale107.622,804301,76616,042Feb 10
Tuer Patrick WilliamEVP, Chief Operating OfficerAug 27 '25Sale123.591,020126,06218,846Aug 27
Tarr Mark JPresident & CEOMay 20 '25Option Exercise40.10118,3844,747,112645,454May 20
Tarr Mark JPresident & CEOMay 20 '25Sale121.53118,38414,387,152527,070May 20
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.